K2 Medical Research

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease5 trials

Phase

• Phase 22 trials
• Phase 32 trials
• Phase 2/31 trial

Status

• Active, not recruiting3 trials
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Annovis Bio Inc.2 trials
• Asceneuron S.A.1 trial
• Eisai Inc.1 trial
• Eli Lilly and Company1 trial

Running trials

• Active, not recruiting

  A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

  NCT06709014· Phase 3· Annovis Bio Inc.· Source

• Active, not recruiting

  A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease

  NCT06602258· Phase 2· Eisai Inc.· Source

• Active, not recruiting

  A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)

  NCT05738486· Phase 3· Eli Lilly and Company· Source

Closed trials

• Terminated

  Study of ASN51 in Adults With Early Alzheimer's Disease

  NCT06677203· Phase 2· Asceneuron S.A.· Source

• Completed

  A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD

  NCT05686044· Phase 2/3· Annovis Bio Inc.· Source